132 related articles for article (PubMed ID: 16793209)
1. Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.
Steurer M; Pall G; Richards S; Schwarzer G; Bohlius J; Greil R;
Cancer Treat Rev; 2006 Aug; 32(5):377-89. PubMed ID: 16793209
[TBL] [Abstract][Full Text] [Related]
2. Purine antagonists for chronic lymphocytic leukaemia.
Steurer M; Pall G; Richards S; Schwarzer G; Bohlius J; Greil R
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD004270. PubMed ID: 16856041
[TBL] [Abstract][Full Text] [Related]
3. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
4. Novel treatment strategies in chronic lymphocytic leukemia.
Weiss MA
Curr Oncol Rep; 2001 May; 3(3):217-22. PubMed ID: 11296131
[TBL] [Abstract][Full Text] [Related]
5. A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.
Kimby E; Brandt L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):224-30. PubMed ID: 11441934
[TBL] [Abstract][Full Text] [Related]
6. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
7. New purine analogues for the treatment of chronic B-cell malignancies.
Gribbin TE
Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
[TBL] [Abstract][Full Text] [Related]
8. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
Bergmann L
Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835
[TBL] [Abstract][Full Text] [Related]
9. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
Nabhan C; Gartenhaus RB; Tallman MS
Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894
[TBL] [Abstract][Full Text] [Related]
10. Purine analogs in the treatment of chronic lymphocytic leukemia.
Pott C; Hiddemann W
Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
[TBL] [Abstract][Full Text] [Related]
11. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
Kay NE
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
[TBL] [Abstract][Full Text] [Related]
12. The effect of p53 dysfunction on purine analogue cytotoxicity in chronic lymphocytic leukaemia.
Pettitt AR; Sherrington PD; Cawley JC
Br J Haematol; 1999 Sep; 106(4):1049-51. PubMed ID: 10520012
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.
Richards S
Cancer Treat Rev; 2005 Jun; 31(4):332-5. PubMed ID: 15894429
[No Abstract] [Full Text] [Related]
14. Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukemia: a systematic review and meta-analysis.
Zhu Q; Tan DC; Samuel M; Chan ES; Linn YC
Leuk Lymphoma; 2004 Nov; 45(11):2239-45. PubMed ID: 15512812
[TBL] [Abstract][Full Text] [Related]
15. Adverse and beneficial immunological effects of purine nucleoside analogues.
Dighiero G
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S75-81. PubMed ID: 9137960
[TBL] [Abstract][Full Text] [Related]
16. Pentostatin in chronic lymphocytic leukemia.
Sauter C; Lamanna N; Weiss MA
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
[TBL] [Abstract][Full Text] [Related]
17. The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials.
Robak T
Leuk Lymphoma; 2002 Mar; 43(3):537-48. PubMed ID: 12002757
[TBL] [Abstract][Full Text] [Related]
18. Immunological and genetic abnormalities in chronic lymphocytic leukaemia. Impact of the purine analogues.
Juliusson G
Drugs; 1994; 47 Suppl 6():19-29. PubMed ID: 7525186
[TBL] [Abstract][Full Text] [Related]
19. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
20. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
Robak T
Drugs Aging; 2005; 22(12):983-1012. PubMed ID: 16363884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
